Katagiri K, Yokosawa H, Kinashi T, Kawashima S, Irie S, Tanaka K, Katagiri T
Institute of Biomatrix, Nippi Inc., Tokyo, Japan.
J Leukoc Biol. 1999 Jun;65(6):778-85. doi: 10.1002/jlb.65.6.778.
Membrane-permeable proteasome inhibitors, lactacystin (LC) and N-acetyl-Leu-Leu-norleucinal (ALLN), but not calpain inhibitor Z-Leu-leucinal (ZLL), prevented LFA-1/ICAM-1-dependent cellular adhesion of TPA-stimulated HL-60 cells. These proteasome inhibitors affected neither the induction of monocytic differentiation nor the accompanying protein-tyrosine phosphorylation. They suppressed the increase in the avidity of LFA-1 to ICAM-1 without changing the expression of these molecules. Immunoblotting using monoclonal antibody FK-1, which reacts specifically with polyubiquitinated proteins, demonstrated that the proteasome inhibitors caused the drastic accumulation of the polyubiquitinated proteins in the membrane fraction of TPA-treated HL-60 cells. This indicates that accompanying activation of LFA-1, TPA induces the polyubiquitination of the membrane proteins, which are rapidly degraded by proteasomes. These data taken together show that proteolysis mediated by the ubiquitin-proteasome system is a prerequisite for the induction of LFA-1-dependent adhesion of HL-60 cells.
膜通透性蛋白酶体抑制剂乳胞素(LC)和N - 乙酰 - 亮氨酰 - 亮氨酰 - 正亮氨酸(ALLN),而非钙蛋白酶抑制剂Z - 亮氨酰 - 亮氨酸(ZLL),可阻止佛波酯(TPA)刺激的HL - 60细胞依赖淋巴细胞功能相关抗原1(LFA - 1)/细胞间黏附分子1(ICAM - 1)的细胞黏附。这些蛋白酶体抑制剂既不影响单核细胞分化的诱导,也不影响伴随的蛋白酪氨酸磷酸化。它们抑制了LFA - 1对ICAM - 1亲和力的增加,而不改变这些分子的表达。使用特异性与多泛素化蛋白反应的单克隆抗体FK - 1进行免疫印迹分析表明,蛋白酶体抑制剂导致TPA处理的HL - 60细胞的膜部分中多泛素化蛋白大量积累。这表明伴随LFA - 1的激活,TPA诱导膜蛋白多泛素化,而这些膜蛋白会被蛋白酶体迅速降解。综合这些数据表明,泛素 - 蛋白酶体系统介导的蛋白水解是诱导HL - 60细胞依赖LFA - 1的黏附的先决条件。